Anavex Life Sciences Corp. earnings releases AVXL

Annual Quarterly

Anavex Life Sciences Corp. last reported quarterly results on Jul 30, 2026, for Q3 FY2026 (the quarter ended Jun 30, 2026): diluted EPS of $0.08. It usually reports 30–56 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 24, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–56 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Jul 30, 2026
30 days after quarter end
Q3 FY2026
ended Jun 30, 2026
—
8
+159.1%
0.08
+150.0%
Feb 9, 2026
40 days after quarter end
Q1 FY2026
ended Dec 31, 2025
—
-6
+53.1%
-0.06
+57.1%
Nov 25, 2025
56 days after quarter end
Q4 FY2025
ended Sep 30, 2025
—
-10
+15.4%
0.00
+100.0%
May 9, 2024
39 days after quarter end
—
ended Mar 31, 2024
—
—
—

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AVXL (Nasdaq)
Fiscal year ends
September 30
Headquarters
New York, NY
SEC filer status
Large accelerated filer, Smaller reporting company
SEC CIK
1314052
Former names
Thrifty Printing Inc. (until Jan 25, 2007)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.